rs35732567
Variant names: 
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001369.3(DNAH5):c.7609+19C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.387 in 1,549,262 control chromosomes in the GnomAD database, including 117,563 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
 Genomes: 𝑓 0.38   (  11042   hom.,  cov: 32) 
 Exomes 𝑓:  0.39   (  106521   hom.  ) 
Consequence
 DNAH5
NM_001369.3 intron
NM_001369.3 intron
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  0.0950  
Publications
5 publications found 
Genes affected
 DNAH5  (HGNC:2950):  (dynein axonemal heavy chain 5) This gene encodes a dynein protein, which is part of a microtubule-associated motor protein complex consisting of heavy, light, and intermediate chains. This protein is an axonemal heavy chain dynein. It functions as a force-generating protein with ATPase activity, whereby the release of ADP is thought to produce the force-producing power stroke. Mutations in this gene cause primary ciliary dyskinesia type 3, as well as Kartagener syndrome, which are both diseases due to ciliary defects. [provided by RefSeq, Oct 2009] 
DNAH5 Gene-Disease associations (from GenCC):
- primary ciliary dyskinesia 3Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), G2P, ClinGen
- primary ciliary dyskinesiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91). 
BP6
Variant 5-13810040-G-A is Benign according to our data. Variant chr5-13810040-G-A is described in ClinVar as Benign. ClinVar VariationId is 197516.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. 
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.607  is higher than 0.05. 
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| DNAH5 | ENST00000265104.5 | c.7609+19C>T | intron_variant | Intron 45 of 78 | 1 | NM_001369.3 | ENSP00000265104.4 | |||
| DNAH5 | ENST00000681290.1 | c.7564+19C>T | intron_variant | Intron 45 of 78 | ENSP00000505288.1 | |||||
| DNAH5 | ENST00000512443.1 | n.465+19C>T | intron_variant | Intron 1 of 2 | 3 | 
Frequencies
GnomAD3 genomes  0.377  AC: 57223AN: 151922Hom.:  11038  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
57223
AN: 
151922
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.393  AC: 60520AN: 154048 AF XY:  0.390   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
60520
AN: 
154048
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.388  AC: 542739AN: 1397226Hom.:  106521  Cov.: 35 AF XY:  0.387  AC XY: 266642AN XY: 689292 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
542739
AN: 
1397226
Hom.: 
Cov.: 
35
 AF XY: 
AC XY: 
266642
AN XY: 
689292
show subpopulations 
African (AFR) 
 AF: 
AC: 
10313
AN: 
31578
American (AMR) 
 AF: 
AC: 
14558
AN: 
35844
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
9041
AN: 
25154
East Asian (EAS) 
 AF: 
AC: 
20544
AN: 
35856
South Asian (SAS) 
 AF: 
AC: 
27066
AN: 
79204
European-Finnish (FIN) 
 AF: 
AC: 
17781
AN: 
49160
Middle Eastern (MID) 
 AF: 
AC: 
1481
AN: 
4068
European-Non Finnish (NFE) 
 AF: 
AC: 
419427
AN: 
1078568
Other (OTH) 
 AF: 
AC: 
22528
AN: 
57794
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.488 
Heterozygous variant carriers
 0 
 16852 
 33705 
 50557 
 67410 
 84262 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
 0 
 13296 
 26592 
 39888 
 53184 
 66480 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  0.377  AC: 57252AN: 152036Hom.:  11042  Cov.: 32 AF XY:  0.376  AC XY: 27921AN XY: 74302 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
57252
AN: 
152036
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
27921
AN XY: 
74302
show subpopulations 
African (AFR) 
 AF: 
AC: 
13490
AN: 
41478
American (AMR) 
 AF: 
AC: 
6101
AN: 
15288
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
1272
AN: 
3470
East Asian (EAS) 
 AF: 
AC: 
3224
AN: 
5162
South Asian (SAS) 
 AF: 
AC: 
1659
AN: 
4812
European-Finnish (FIN) 
 AF: 
AC: 
3729
AN: 
10576
Middle Eastern (MID) 
 AF: 
AC: 
109
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
26371
AN: 
67940
Other (OTH) 
 AF: 
AC: 
820
AN: 
2106
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.502 
Heterozygous variant carriers
 0 
 1844 
 3688 
 5533 
 7377 
 9221 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 566 
 1132 
 1698 
 2264 
 2830 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
1562
AN: 
3478
ClinVar
Significance: Benign 
Submissions summary: Benign:8 
Revision: criteria provided, multiple submitters, no conflicts
LINK: link 
Submissions by phenotype
not specified    Benign:4 
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
Mar 16, 2016
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided    Benign:2 
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Nov 11, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Primary ciliary dyskinesia    Benign:1 
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Primary ciliary dyskinesia 3    Benign:1 
Jun 15, 2021
Pars Genome Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.